MassDevice.com +5 | The top 5 medtech stories for May 1, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Abbott wins $11m DoD contract for brain injury diagnostic dev Abbott won an $11.3 million contract with the US Department of Defense for the development of traumatic brain injury assays, according to a DoD released last Friday. The contract is with the US Army Medical Research Acquisition Activity in Frederick, Md., with an initial $2.5 million obligated at the time it was issued. Read more 4. Cardinal Health’s fiscal Q3 earnings top forecast, but sales miss the mark Fiscal 3rd-quarter earnings for Cardinal Health came in ahead of the consensus estimate on Wall Street, but the top line missed expectations by nearly $500 million. The Dublin, Ohio-based company posted profits of $381 million, or $1.20 per share, on sales of $31.82 billion for the 3 months ended March 31, for a bottom-line slide of-1.3% on sales growth of 3.8% compared with Q3 2016. Read more 3. Medtronic wins FDA nod for Resolute Onyx drug-eluting stent Medtronic said today that the FDA approved its Resolute Onyx drug-eluting stent. The Fridley, Minn.-based company touted its device as the 1st sten...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news